|
|
|
Name
|
Genaissance Pharmaceuticals |
|
Address:
|
5 Science Park
|
|
City:
|
New Haven
|
|
State:
|
CT
|
|
Zip:
|
06511
|
|
Phone
|
203-773-1450
|
|
Web
Site:
|
www.genaissance.com
|
|
Fax:
|
492-4473
|
|
No. Employees
|
145
|
|
No. Researchers
|
120
|
|
Capitalization
|
$54,480,000
|
|
R&D Spending
|
$19,900,000
|
|
Major Investors
|
Dresden Kelenword Benson, International Biomedical Mgmt.
|
|
Strategic Alliances
|
Pharmaceutical, diagnostic & biotech cos, government & academic research groups
|
|
Products
|
Pharmacogenetics
|
|
CFO
|
Ben D. Kaplan
|
|
Chief Scientific Research Officer
|
Richard S. Judson
|
|
Ownership
|
Public (NASDAQ: GNSC)
|
|
CEO
|
Kevin Rakin
|
|
Year Founded
|
1997
|
|
President
|
Kevin Rakin
|
|
|
|
|
|
|
|
Human Resource Manager/Director
|
Jennifer Barretta
|
|
|
